No Picture
Trading Ideas

Regeneron To Repurchase $5 Billion Stake From Sanofi

U.S. biotech company Regeneron Pharmaceuticals, Inc (REGN) said on Monday that it will repurchase $5 billion of common stock held by France’s Sanofi.The biotech firm said that the offering will have no impact on its ongoing collaboration with Sanofi formed in 2003. Regeneron will fund the purchase with a combination of $3.5 billion of cash on hand and $1.5 billion of fully-committed bridge financing from Goldman Sachs Bank USA.“Sanofi and Regeneron’s collaboration has been one of the most productive in the industry, creating significant value for both companies but more importantly, resulting in five important medicines for patients,” said Sanofi …read more […]

No Picture
Trading Ideas

Sanofi to Sell Regeneron Stake Worth About $13 Billion

(Bloomberg) — French drug giant Sanofi is selling a stake in Regeneron Pharmaceuticals Inc. valued at about $13 billion.Regeneron has agreed to repurchase $5 billion of its stock from Sanofi, the companies said on Monday. Regeneron said Sanofi also plans to sell approximately 12.8 million shares through a public offering.The announcement is part of Sanofi Chief Executive Officer Paul Hudson’s revamped strategy for the drugmaker. Sanofi announced in December that it would end its hunt for new diabetes and heart disease drugs, helping save more than $2 billion, and focus on fast-growing fields such as cancer.Sanofi currently holds about 23.2 …read more […]

No Picture
Trading Ideas

'Oh my gosh… I didn't know': Joy, confusion over money allocated for niche U.S. schools amid coronavirus

What do a jazz school, a yeshiva, and a dog training academy have in common?

They were all allocated hundreds of thousands of dollars by the Department of Education (ED) to help them weather the coronavirus pandemic. …read more […]